Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00884377 · ClinicalTrials.gov registry record · Phase 2
Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
A Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT00884377 is a Phase 2 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 56 participants.
The verdict
NCT00884377, a Phase 2 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study serves to compare the effectiveness of treating cutaneous leishmaniasis with either intravenous sodium stibogluconate or direct heat therapy using the ThermoMed-TM device.
Interventions
- DRUG Sodium stibogluconate (Pentostam)
- DEVICE ThermoMed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00884377
The ClinicalTrials.gov registry entry for NCT00884377 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium stibogluconate (Pentostam) is the first listed.
NCT00884377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00884377 about?
NCT00884377 is a clinical study titled "Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis". This study serves to compare the effectiveness of treating cutaneous leishmaniasis with either intravenous sodium stibogluconate or direct heat therapy using the ThermoMed-TM device.
What is the current status of trial NCT00884377?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2004-02. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00884377?
The interventions under investigation include: Sodium stibogluconate (Pentostam) (DRUG), ThermoMed (DEVICE).
Who is sponsoring clinical trial NCT00884377?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.